Anna Masajtis-Zagajewska

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Placebo Controlled

Chronic Kidney Disease

Top Venues

Journal of the renin-angiotensin-aldosterone system : JRAAS

Medicina (Kaunas, Lithuania)

The American journal of case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Joanna Korzycka, Ewa Pawłowicz, Anna Masajtis-Zagajewska, Michał Nowicki
Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy. The American journal of case reports 23 (2022)
Anna Masajtis-Zagajewska, Jacek Majer, Michal Nowicki
Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome. Journal of the renin-angiotensin-aldosterone system : JRAAS 2021 (2021)
Anna Masajtis-Zagajewska, Tomasz Hołub, Katarzyna Pęczek, Agnieszka Makówka, Michal Nowicki
Different Effects of Empagliflozin on Markers of Mineral-Bone Metabolism in Diabetic and Non-Diabetic Patients with Stage 3 Chronic Kidney Disease. Medicina (Kaunas, Lithuania) 57 (12) (2021)
Piotr Ruszkowski, Anna Masajtis-Zagajewska, Michał Nowicki
Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study. Journal of the renin-angiotensin-aldosterone system : JRAAS 20 (3) (2020)